• Contact
Friday, June 6, 2025
Register
Login
European Press
Advertisement
  • News
  • Business
  • Tech
  • Sport
  • Health
  • Entertainment
  • Lifestyle
  • Video
No Result
View All Result
  • News
  • Business
  • Tech
  • Sport
  • Health
  • Entertainment
  • Lifestyle
  • Video
No Result
View All Result
European Press
No Result
View All Result

Scripta Insights, RxSaveCard partner for lower prescription drug costs

4 June 2025
in Health
Reading Time: 2 mins read
A A
Scripta Insights, RxSaveCard partner for lower prescription drug costs
ShareShareShareShareShare


Scripta Insights, a company that develops pharmacy navigation solutions for self-insured employers, health plans and members, is entering into a strategic partnership with RxSaveCard, which offers pharmacy benefit cost-containment and payment options.
The partnership aims to help self-insured employers fulfill their fiduciary obligations and reduce prescription drug costs by providing members with access to affordable medication options, whether covered by their health plan or via cash-pay alternatives.
In a statement, Scripta explained that it will integrate RxSaveCard into its Rx Navigation platform, which the company says will benefit clients who have the fully customized solution in place. 
For members, it aims to help them save on high-cost specialty drugs, including GLP-1s. 
For self-insured employers, the goal is to reduce plan spend by avoiding traditional pharmacy benefit manager (PBM) markups.
Additionally, Scripta will steer members to the most cost-effective medication options available. 
That could mean a covered drug through their health plan, converting to a less expensive alternative or using a cash pay source like RxSaveCard. 
Scripta stated that the RxSaveCard also permits plan sponsors to offer low- or no-cost medications to members without requiring a switch to a new PBM. 
Additionally, employers fund a prepaid digital card every month that covers all or part of the targeted drug costs. 
Members will be able to use the card at over 65,000 pharmacies, including Mark Cuban Cost Plus Drugs and Lilly Direct, with the employer-funded amount applied automatically at checkout.
According to Scripta, members will have the ability to search for RxSaveCard discounted prices and pharmacy alternatives and access their cards directly in the Scripta member app. Scripta will also provide clients with detailed reporting on their savings.
“RxSaveCard shares our commitment to innovating the traditional pharmacy benefits model and putting patients back in control of their prescription choices,” Eric Levin, CEO of Scripta Insights, said in a statement. 
“By integrating RxSaveCard’s nationwide discount network into our Scripta Savings Mapper, we’re making it even easier for members to compare all their options, including new cash pay alternatives, and save money on their prescriptions.”
THE LARGER TREND
In May, Scripta Insights launched its GLP-1 Navigator, a tool in the Scripta member app that provides patients with information about GLP-1 medications in a centralized guide. 
Updated weekly, Scripta’s GLP-1 Navigator helps members understand their options and the trade-offs, regardless of whether their plan covers GLP-1s.
In 2024, Scripta Insights announced it raised $17 million in Series B funding, led by Aquiline, bringing its total funding to $42 million at the time.
Contour Venture Partners, Eastside Partners and ReMY Investors participated in the round.   
In 2023, Scripta Insights collaborated with Mark Cuban Cost Plus Drug Company. 
In a statement, the company said the relationship furthered Scripta’s mission to get members the right meds at the best price.
In 2024, RxSaveCard raised $1.7 million in seed funding to drive growth and expand consumer access to affordable medications.
According to BusinessWire, the round was led by Distributed Ventures, with participation from industry insiders.

Credit: Source link

Related Posts:

  • Scripta Insights, RxSaveCard partner for lower prescription drug costs
    Scripta Insights, RxSaveCard partner for lower…
  • Mark Cuban Cost Plus Drug Company partners with specialty pharmaceutical distributor
    Mark Cuban Cost Plus Drug Company partners with…
  • Serve You Rx, Amazon Pharmacy partner for home delivery
    Serve You Rx, Amazon Pharmacy partner for home delivery
  • Talkspace integrates with Amazon Pharmacy for psychiatry services
    Talkspace integrates with Amazon Pharmacy for…
ShareTweetSendPinShare
Previous Post

CVS Health commits $20B to health-tech initiatives

Next Post

A-ha star Morten Harket reveals heartbreaking Parkinson’s disease diagnosis: ‘Know that I am being taken care of’

Next Post
A-ha star Morten Harket reveals heartbreaking Parkinson’s disease diagnosis: ‘Know that I am being taken care of’

A-ha star Morten Harket reveals heartbreaking Parkinson’s disease diagnosis: 'Know that I am being taken care of'

Recommended

The Last of Us Season 2 finale trailer promises one hell of a fight

The Last of Us Season 2 finale trailer promises one hell of a fight

19 May 2025
Trump set to announce major UK-US trade deal amid global tariff fallout

Trump set to announce major UK-US trade deal amid global tariff fallout

8 May 2025
Gregg Popovich was ‘barely responding’ during medical incident

Gregg Popovich was ‘barely responding’ during medical incident

24 May 2025
Chef Alain Ducasse: The mind behind the innovative culinary empire | The Dialogue

Chef Alain Ducasse: The mind behind the innovative culinary empire | The Dialogue

3 June 2025
Sophie Cunningham accused of having affair with Suns, Mercury CEO in bombshell lawsuit

Sophie Cunningham accused of having affair with Suns, Mercury CEO in bombshell lawsuit

20 May 2025
European Press

European-press.com shares the latest news from Europe and around the world. It covers topics such as business, technology, sports, health, entertainment, and lifestyle. Feel free to get in touch with us!

Disclaimer  Privacy Policy – EU  Imprint 

Contact Us

What’s New Here!

  • Euronews Debates: What’s the outlook for e-IDs ahead of the Swiss referendum?
  • University of New South Wales trials brain game for chronic pain treatment
  • Elon Musk and Donald Trump’s feud has exploded
  • My family is not supportive of my health journey

Subscribe to Our Newsletter

Copyright 2025 © EUROPEAN PRESS All rights on our posts reserved!

Translate »
European Press
Manage Cookie Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behaviour or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
Manage options Manage services Manage {vendor_count} vendors Read more about these purposes
View preferences
{title} {title} {title}
No Result
View All Result
  • News
  • Business
  • Tech
  • Sport
  • Health
  • Entertainment
  • Lifestyle
  • Video

Copyright 2025 © EUROPEAN PRESS All rights on our posts reserved!

Are you sure want to unlock this post?
Unlock left : 0
Are you sure want to cancel subscription?
×